Page last updated: 2024-09-04

tariquidar and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

tariquidar has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 2 studies

Compound Research Comparison

Studies
(tariquidar)
Trials
(tariquidar)
Recent Studies (post-2010)
(tariquidar)
Studies
(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)
Trials
(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)
Recent Studies (post-2010) (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)
210161381,92811,354

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB1
Ambudkar, SV; Lusvarghi, S; Raju, N; Sajid, A; Swenson, RE; Vahedi, S1

Other Studies

2 other study(ies) available for tariquidar and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

ArticleYear
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
    Experimental parasitology, 2013, Volume: 134, Issue:2

    Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines

2013
Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Drug metabolism and disposition: the biological fate of chemicals, 2019, Volume: 47, Issue:10

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Azoles; Boron Compounds; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Dyes; HeLa Cells; Humans; Inhibitory Concentration 50; Microscopy, Fluorescence; Molecular Docking Simulation; Molecular Imaging; Molecular Probes; Neoplasms; Nitrobenzenes; Quinolines; Recombinant Proteins

2019